We recently published an article looking at how multinationals are
diversifying into new markets and sectors through the process (and
power) of technological transformation. In that article we focused
on FUJIFILM and we mentioned how other companies were undergoing
the same transformational process; one such company is BAT (until
very recently known as British American Tobacco).
BAT has announced that it has used its vast resources and
scientific knowledge of tobacco plants to help develop a vaccine
for the novel coronavirus COVID-19, which could be manufactured
from June this year, to help fight the ongoing global pandemic. The
new innovation has now moved to pre-clinical testing and BAT has
said that it will work on the vaccine on a not-for-profit
basis.
